[A review of 3D printing via fused deposition modeling in pharmaceutics].

药学学报 Pub Date : 2016-11-01

Dong-lin He, Fu-guo Han, Zhao Wang, Qing-fei Liu

引用次数: 0

Abstract

Three dimensional printing (3D printing) has been known as additive manufacturing technique based on digitally-controlled deposition of materials. Fused deposition modeling (FDM) is one of techniques commonly used in 3D printing, in which materials are soften or melt by heat to create objects during printing. This paper is prepared to review the research and application of 3D printing via FDM in the pharmaceutical sciences, including its advantages and limitations.

本刊更多论文

[通过熔融沉积建模在制药领域的3D打印综述]。

三维打印(3D打印)被称为基于数字控制的材料沉积的增材制造技术。熔融沉积建模(FDM)是3D打印中常用的技术之一，其中材料在打印过程中被加热软化或熔化以创建物体。本文综述了FDM技术在制药领域的研究和应用，包括其优势和局限性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

药学学报 Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)

CiteScore

1.20

自引率

0.00%

发文量

期刊介绍： Acta Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes significant original research articles, communications and high quality reviews of recent advances. APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics. APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953. The journal is co-published by Elsevier B.V., in association with the Institute of MateriaMedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.